FDA warns Chinese company for drug manufacturing data integrity violations

The organization sent Ningbo Huize Commodity a warning letter for significant current good manufacturing practice violations, including data integrity issues.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news